UBS Group AG Decreases Stock Position in Select Medical Holdings Corporation $SEM

UBS Group AG lowered its stake in Select Medical Holdings Corporation (NYSE:SEMFree Report) by 42.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 188,793 shares of the health services provider’s stock after selling 141,772 shares during the quarter. UBS Group AG’s holdings in Select Medical were worth $2,804,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Mitsubishi UFJ Trust & Banking Corp lifted its stake in Select Medical by 889.7% in the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 64,094 shares of the health services provider’s stock worth $823,000 after purchasing an additional 57,618 shares in the last quarter. Dana Investment Advisors Inc. lifted its stake in Select Medical by 52.9% in the 3rd quarter. Dana Investment Advisors Inc. now owns 524,621 shares of the health services provider’s stock worth $6,736,000 after purchasing an additional 181,436 shares in the last quarter. Public Sector Pension Investment Board lifted its stake in Select Medical by 21.3% in the 3rd quarter. Public Sector Pension Investment Board now owns 430,472 shares of the health services provider’s stock worth $5,527,000 after purchasing an additional 75,530 shares in the last quarter. Western Standard LLC purchased a new stake in Select Medical in the 3rd quarter worth $13,551,000. Finally, CSM Advisors LLC lifted its stake in Select Medical by 32.0% in the 3rd quarter. CSM Advisors LLC now owns 298,961 shares of the health services provider’s stock worth $3,840,000 after purchasing an additional 72,546 shares in the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on SEM. Zacks Research upgraded shares of Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. Weiss Ratings restated a “hold (c-)” rating on shares of Select Medical in a research report on Wednesday, May 20th. Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 target price (down from $19.00) on shares of Select Medical in a research report on Tuesday, March 3rd. Finally, Mizuho restated a “neutral” rating and set a $16.50 target price (down from $17.00) on shares of Select Medical in a research report on Tuesday, May 12th. One research analyst has rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $15.50.

Read Our Latest Stock Analysis on SEM

Select Medical Stock Up 0.1%

Shares of NYSE SEM opened at $16.54 on Tuesday. The firm’s 50-day moving average price is $16.39 and its 200-day moving average price is $15.52. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $2.05 billion, a price-to-earnings ratio of 15.61, a P/E/G ratio of 0.95 and a beta of 1.02. Select Medical Holdings Corporation has a 12-month low of $11.65 and a 12-month high of $16.99.

Select Medical (NYSE:SEMGet Free Report) last announced its earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.07). The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.44 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, equities research analysts anticipate that Select Medical Holdings Corporation will post 1.26 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 28th. Investors of record on Thursday, May 14th will be issued a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.5%. The ex-dividend date is Thursday, May 14th. Select Medical’s dividend payout ratio is presently 23.58%.

Select Medical declared that its Board of Directors has approved a stock repurchase plan on Thursday, February 19th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the health services provider to purchase up to 49.5% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.

Select Medical Profile

(Free Report)

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.

Featured Stories

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Corporation (NYSE:SEMFree Report).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.